Critical Care

official impact factor 4.60

Open Access Research

Exogenous nitric oxide requires an endothelial glycocalyx to prevent postischemic coronary vascular leak in guinea pig hearts

Dirk Bruegger*, Markus Rehm, Matthias Jacob, Daniel Chappell, Mechthild Stoeckelhuber, Ulrich Welsch, Peter Conzen and Bernhard F Becker

Critical Care 2008, 12:R73 doi:10.1186/cc6913

Many facets of NO

Heikki Savolainen   (2008-07-31 09:17)  Dept. of Occup.Safety & Health, Tampere, Finland email

NO is a party of many redox reactions. Therefore, it is a powerful physiological mediator. In case of hypoxia or ischemia, all of the NO-mediated reactions may not be regarded beneficial. Among these one may name the vasodilatation and competition with molecular oxygen for its binding site in the terminal cytochrome oxidase in the mitochondria. It is competetively inhibited at 100-340 nM NO (1).

Another aspect is that the proteoglycans which maintain the integrity of the inner vessel wall also participate in many other functions, like coagulation (2). Therefore, the treatment aimed at them, while promising, must be regarded experimental.

1 Antunes F, Boveris A, Cadenas E. Proc Ntl Acad Sci. 2004; 101: 16774

2 Savolainen H. J Chromatogr B. 1999; 722: 255

Competing interests

None

top

Post a comment